PLATINUM
Official label name (INCIInternational name of cosmetic ingredients: the one printed on the pack. name, EU glossary of cosmetic ingredient names), No 21314
- Prohibited in nano form (Annex II)
PLATINUM: Prohibited in nano form (Annex II, entry 1729), under Regulation (EC) No 1223/2009. Annexes of the Regulation consulted on 21 October 2026.
Who it concerns
What official classifications and rules say for each group. A classification describes the hazard of the pure substance, not the risk of a product that contains it, which depends on the dose and the exposure.
Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.
Pregnancy and breastfeeding
No classification harmonised by the European Union covers reproduction, the unborn child or breastfeeding for this substance. This does not mean it has been judged to have no effect during pregnancy.
Babies and children
The Cosmetics Regulation sets no age-related condition for this ingredient.
Skin, eyes and allergies
No official classification for sensitisation, irritation or eye damage, and no obligation to label it as an allergen.
Environment
No official classification as hazardous to the aquatic environment and no assessment as an endocrine disruptor for the environment.
Read on the label
The Cosmetics Regulation requires no warning to be printed for this ingredient.
In plain words
What it is used for
Functions declared by manufacturers:
Antimicrobial: helps control the growth of micro-organisms on the skin.
Antioxidant: inhibits reactions promoted by oxygen, thus avoiding oxidation and rancidity.
Skin conditioning: maintains the skin in good condition.
What the rules say
Only the nanomaterial form is prohibited; the non-nano form is not covered by this entry. On an ingredient list, the nanomaterial form is marked [nano].
The text of the annexes
Prohibited in nano form
CosIng links the name PLATINUM to this entry. The cases of prohibition are explained above, in “In plain words”; the official title is given below.
- Entry
- Annex II, No 1729
- Substance
- Platinum (nano) [INCI], Colloidal Platinum (nano) [INCI] [1] Acetyl tetrapeptide-17 Colloidal Platinum (nano) [INCI] [2]
- CAS
- 7440-06-4 [1]/ - [2]
- EC
- 231-116-1 [1]/ - [2]
Dates in the act (3)
- Entry into force on 4 April 2024
- Placing on the market from 1 February 2025
From 1 February 2025 cosmetic products containing that substance shall not be placed on the Union market
- Making available from 1 November 2025
From 1 November 2025 cosmetic products containing that substance shall not be made available on the Union market
Excerpts from the English text published in the Official Journal. A date may concern only some substances of the act: the excerpt says so.
What has changed, and what will change
Dates of the texts that cover this ingredient. A text date may cover several substances: the details of each entry are below.
Annex II, entry 1729: introduced or replaced by Regulation (EU) 2024/858
Annex II, entry 1729: applies from this date
Identity
- CosIng identifier
- 89486
- CAS (according to CosIng)
- 7440-06-4
- EC (according to CosIng)
- 231-116-1
- Declared functions
- Antimicrobial, Antioxidant, Skin conditioning
The CAS number cited by CosIng also covers 2 other INCI names: it designates a family of substances, not this ingredient alone.
Elsewhere in the world
Information on other jurisdictions, with no effect on sale in France. What is covered, and what is not yet.
Comparison between countries
Most restrictive status in each country, and the maximum concentration cited. The details and the source of each rule follow.
| Country | Rule | Maximum concentration cited |
|---|---|---|
| European Union | Prohibited in nano form | not cited |
| United Kingdom | No specific rule in the Cosmetics Regulation | not cited |
| Switzerland | EU Regulation applies | not cited |
| United States (federal) | No federal rule recorded | not cited |
| Japan | No entry in the lists recorded | not cited |
| South Korea | No entry in the lists recorded | not cited |
| China | No entry in the lists recorded | not cited |
| Australia | No entry in the lists recorded | not cited |
| Brazil | No entry in the lists recorded | not cited |
United Kingdom (Great Britain)
- No specific rule in the Cosmetics Regulation
Entry 1729 of Annex II of EU law (Regulation (EU) 2024/858) has no equivalent in British law.
Switzerland
Regulation (EC) No 1223/2009 applies in Switzerland (Article 54 of the Ordinance on Foodstuffs and Utility Articles).
United States, federal rules
None of the integrated sections of the federal code (21 CFR 700.11 to 700.27 and 250.250) targets this name. The FDA does not publish a list of allowed ingredients.
Recorded cosmetics that contain it
1 recorded product list it, according to Open Beauty Facts contributors. Records are dated: the formula may have changed. See the list (in French).
Glossary: Commission Implementing Decision (EU) 2025/1175. Page updated on 21 October 2026.